Argitalpenak (6) IDOIA BILBAO MESEGUER argitalpenak

2022

  1. Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study

    Journal of Intensive Care, Vol. 10, Núm. 1

2021

  1. Population pharmacokinetics of levetiracetam and dosing evaluation in critically ill patients with normal or augmented renal function

    Pharmaceutics, Vol. 13, Núm. 10

2018

  1. Augmented Renal Clearance in Critically Ill Patients: A Systematic Review

    Clinical Pharmacokinetics, Vol. 57, Núm. 9, pp. 1107-1121

2017

  1. Productos para pacientes oncológicos: XIV Curso de Atención Farmacéutica: Preparados alimenticios. Tema 16

    El farmacéutico: profesión y cultura, Núm. 550, pp. 41-48

2015

  1. Drug interactions with sunitinib

    Journal of Oncology Pharmacy Practice, Vol. 21, Núm. 1, pp. 52-66

2014

  1. Gemcitabine: Molecular pharmacology, pharmacogenetics and adverse reaction profile

    Gemcitabine: Pharmacology, Clinical Uses and Potential Side Effects (Nova Science Publishers, Inc.), pp. 1-62